Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
GHRS
#7029
GH Research PLC Ordinary Shares
14.850
0
-3.51%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-3.51%
Monatliche Änderung
-9.12%
6 month change
+4.87%
Jahresänderung
+4.87%
Vorheriger Schlusskurs
15.390
0
Open
14.850
0
Bid
Ask
Low
14.850
0
High
14.850
0
Volumen
22
Märkte
Aktien
Gesundheitswesen
GHRS
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
52.02 M
52.02 M
52.03 M
52.03 M
208.1 M
Valuation ratios
Enterprise value
936.87 M
337.09 M
199.93 M
263.41 M
2.36 B
Price to earnings ratio
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
Price to book ratio
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.03
0.09
0.16
0.21
—
Return on equity %
0.03
0.09
0.16
0.22
—
Return on invested capital %
—
—
—
—
—
Gross margin %
—
—
—
—
—
Operating margin %
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
Net margin %
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
101.8
37.07
24.49
17.23
—
Inventory turnover
—
—
—
—
—
Asset turnover
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
—
—
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
—
—
—
—
Net current asset value per share
—
—
—
—
—
Tangible book value per share
—
—
—
—
—
Working capital per share
—
—
—
—
—
Book value per share
—
—
—
—
—
Nachrichten
RBC Capital erhöht Kursziel für GH Research auf 40 US-Dollar
GH Research stock price target raised to $40 from $33 at RBC Capital
Eli Lilly and Regencell among market cap stock movers on Wednesday
Needham hebt Kursziel für GH Research deutlich auf 29 US-Dollar an
GH Research stock price target raised to $29 from $19 at Needham
GH Research: Aktie springt nach Aufhebung des FDA-Genehmigungsstopps – Canaccord erhöht Kursziel
GH Research stock jumps as Canaccord raises price target on FDA hold lift
GH Research: FDA hebt "Clinical Hold" für Medikamentenkandidaten auf – Aktie springt an
GH Research stock rises as FDA lifts clinical hold on GH001
Psychedelics-Tied GH Skyrockets On FDA Go-Ahead For Depression Drug
Tesla, Chevron among market cap stock movers on Monday
TD Cowen bestätigt Kaufempfehlung für GH Research